» Articles » PMID: 30227328

MiR-545-3p/MT1M Axis Regulates Cell Proliferation, Invasion and Migration in Hepatocellular Carcinoma

Overview
Date 2018 Sep 19
PMID 30227328
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have shown that metallothionein 1 M (MT1M) is a tumor suppressor gene which is frequently down-regulated in human hepatocellular carcinoma (HCC). The methylation of MT1M promoter region is one of the important transcriptional regulation mechanisms that contribute to the loss of its expression. In our study, we found that there are still half of the 55 HCC tumor tissues in our cohort do not share the promoter methylation of MT1M. So, we speculated there maybe another mechanism participating in the downregulation of MT1M in HCC. Then, we provided evidences that miR-545-3p, which served as a tumor promoter, post-transcriptionally regulate MT1M in HCC through binding to its untranslated region (3'UTR). Taking together, we investigated the role of miR-545-3p in the process of HCC through regulating MT1M.

Citing Articles

Current and future perspectives on the regulation and functions of miR-545 in cancer development.

Shen J, Su X, Wang Q, Ke Y, Zheng T, Mao Y Cancer Pathog Ther. 2024; 2(3):142-154.

PMID: 39027151 PMC: 11252520. DOI: 10.1016/j.cpt.2023.09.001.


Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model.

Chakraborty N, Holmes-Hampton G, Gautam A, Kumar R, Hritzo B, Legesse B Sci Rep. 2023; 13(1):18496.

PMID: 37898651 PMC: 10613244. DOI: 10.1038/s41598-023-45250-9.


Dermatomyositis with intrahepatic cholangiocarcinoma: a case report and data mining based on machine learning.

Zhang X, Chen B Front Oncol. 2023; 13:1206043.

PMID: 37664040 PMC: 10471963. DOI: 10.3389/fonc.2023.1206043.


Risk prediction for dermatomyositis-associated hepatocellular carcinoma.

Zhang X, Ma Y, Liu K, Chen L, Ding L, Ma W BMC Bioinformatics. 2023; 24(1):222.

PMID: 37259059 PMC: 10233868. DOI: 10.1186/s12859-023-05353-6.


Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.

Sgro A, Cursons J, Waryah C, Woodward E, Foroutan M, Lyu R Clin Epigenetics. 2023; 15(1):73.

PMID: 37120619 PMC: 10149030. DOI: 10.1186/s13148-023-01482-0.